vs

Side-by-side financial comparison of MERCURY SYSTEMS INC (MRCY) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

MERCURY SYSTEMS INC is the larger business by last-quarter revenue ($235.8M vs $221.4M, roughly 1.1× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 0.2% vs -1.2%, a 1.4% gap on every dollar of revenue. On growth, MERCURY SYSTEMS INC posted the faster year-over-year revenue change (11.5% vs 6.7%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (11.7% CAGR vs -2.6%).

Mercury Systems, Inc. is a technology company serving the aerospace and defense industry. It designs, develops and manufactures open architecture computer hardware and software products, including secure embedded processing modules and subsystems, avionics mission computers and displays, rugged secure computer servers, and trusted microelectronics components, modules and subsystems.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

MRCY vs UTI — Head-to-Head

Bigger by revenue
MRCY
MRCY
1.1× larger
MRCY
$235.8M
$221.4M
UTI
Growing faster (revenue YoY)
MRCY
MRCY
+4.8% gap
MRCY
11.5%
6.7%
UTI
Higher net margin
UTI
UTI
1.4% more per $
UTI
0.2%
-1.2%
MRCY
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
11.7%
-2.6%
MRCY

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
MRCY
MRCY
UTI
UTI
Revenue
$235.8M
$221.4M
Net Profit
$-2.9M
$433.0K
Gross Margin
99.6%
Operating Margin
72.9%
0.2%
Net Margin
-1.2%
0.2%
Revenue YoY
11.5%
6.7%
Net Profit YoY
-60.5%
EPS (diluted)
$-0.04
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRCY
MRCY
UTI
UTI
Q1 26
$235.8M
$221.4M
Q4 25
$232.9M
$220.8M
Q3 25
$225.2M
$222.4M
Q2 25
$273.1M
$204.3M
Q1 25
$211.4M
$207.4M
Q4 24
$223.1M
$201.4M
Q3 24
$204.4M
$196.4M
Q2 24
$248.6M
$177.5M
Net Profit
MRCY
MRCY
UTI
UTI
Q1 26
$-2.9M
$433.0K
Q4 25
$-15.1M
$12.8M
Q3 25
$-12.5M
$18.8M
Q2 25
$16.4M
$10.7M
Q1 25
$-19.2M
$11.4M
Q4 24
$-17.6M
$22.2M
Q3 24
$-17.5M
$18.8M
Q2 24
$-10.8M
$5.0M
Gross Margin
MRCY
MRCY
UTI
UTI
Q1 26
99.6%
Q4 25
26.0%
Q3 25
27.9%
Q2 25
31.0%
Q1 25
27.0%
Q4 24
27.3%
Q3 24
25.3%
Q2 24
29.5%
Operating Margin
MRCY
MRCY
UTI
UTI
Q1 26
72.9%
0.2%
Q4 25
-4.6%
7.1%
Q3 25
-3.8%
11.2%
Q2 25
8.6%
6.9%
Q1 25
-8.2%
8.1%
Q4 24
-5.6%
13.6%
Q3 24
-6.6%
13.3%
Q2 24
-3.2%
4.2%
Net Margin
MRCY
MRCY
UTI
UTI
Q1 26
-1.2%
0.2%
Q4 25
-6.5%
5.8%
Q3 25
-5.6%
8.4%
Q2 25
6.0%
5.2%
Q1 25
-9.1%
5.5%
Q4 24
-7.9%
11.0%
Q3 24
-8.6%
9.6%
Q2 24
-4.3%
2.8%
EPS (diluted)
MRCY
MRCY
UTI
UTI
Q1 26
$-0.04
$0.01
Q4 25
$-0.26
$0.23
Q3 25
$-0.21
$0.33
Q2 25
$0.28
$0.19
Q1 25
$-0.33
$0.21
Q4 24
$-0.30
$0.40
Q3 24
$-0.30
$0.35
Q2 24
$-0.18
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRCY
MRCY
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$331.8M
$162.0M
Total DebtLower is stronger
$591.5M
$127.8M
Stockholders' EquityBook value
$1.5B
$339.9M
Total Assets
$2.5B
$852.2M
Debt / EquityLower = less leverage
0.40×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRCY
MRCY
UTI
UTI
Q1 26
$331.8M
$162.0M
Q4 25
$335.0M
$162.8M
Q3 25
$304.7M
$169.1M
Q2 25
$309.1M
$70.7M
Q1 25
$269.8M
$96.0M
Q4 24
$242.6M
$172.0M
Q3 24
$158.1M
$161.9M
Q2 24
$180.5M
$115.5M
Total Debt
MRCY
MRCY
UTI
UTI
Q1 26
$591.5M
$127.8M
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
MRCY
MRCY
UTI
UTI
Q1 26
$1.5B
$339.9M
Q4 25
$1.5B
$335.9M
Q3 25
$1.5B
$328.1M
Q2 25
$1.5B
$306.8M
Q1 25
$1.5B
$293.9M
Q4 24
$1.5B
$280.0M
Q3 24
$1.5B
$260.2M
Q2 24
$1.5B
$239.4M
Total Assets
MRCY
MRCY
UTI
UTI
Q1 26
$2.5B
$852.2M
Q4 25
$2.5B
$834.0M
Q3 25
$2.5B
$826.1M
Q2 25
$2.4B
$740.8M
Q1 25
$2.4B
$720.4M
Q4 24
$2.4B
$753.8M
Q3 24
$2.4B
$744.6M
Q2 24
$2.4B
$706.0M
Debt / Equity
MRCY
MRCY
UTI
UTI
Q1 26
0.40×
0.38×
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRCY
MRCY
UTI
UTI
Operating Cash FlowLast quarter
$6.4M
$7.1M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-0.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
16.33×
TTM Free Cash FlowTrailing 4 quarters
$73.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRCY
MRCY
UTI
UTI
Q1 26
$6.4M
$7.1M
Q4 25
$51.6M
$3.1M
Q3 25
$2.2M
$57.1M
Q2 25
$38.1M
$18.1M
Q1 25
$30.0M
$-789.0K
Q4 24
$85.5M
$23.0M
Q3 24
$-14.7M
$67.5M
Q2 24
$71.8M
$10.0M
Free Cash Flow
MRCY
MRCY
UTI
UTI
Q1 26
$-1.8M
Q4 25
$45.7M
$-19.2M
Q3 25
$-4.4M
$40.6M
Q2 25
$34.0M
$6.8M
Q1 25
$24.1M
$-11.7M
Q4 24
$81.9M
$19.6M
Q3 24
$-20.9M
$60.0M
Q2 24
$61.4M
$3.0M
FCF Margin
MRCY
MRCY
UTI
UTI
Q1 26
-0.8%
Q4 25
19.6%
-8.7%
Q3 25
-1.9%
18.3%
Q2 25
12.4%
3.4%
Q1 25
11.4%
-5.7%
Q4 24
36.7%
9.7%
Q3 24
-10.2%
30.6%
Q2 24
24.7%
1.7%
Capex Intensity
MRCY
MRCY
UTI
UTI
Q1 26
Q4 25
2.5%
10.1%
Q3 25
2.9%
7.4%
Q2 25
1.5%
5.5%
Q1 25
2.8%
5.3%
Q4 24
1.6%
1.7%
Q3 24
3.1%
3.8%
Q2 24
4.2%
4.0%
Cash Conversion
MRCY
MRCY
UTI
UTI
Q1 26
16.33×
Q4 25
0.24×
Q3 25
3.04×
Q2 25
2.33×
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons